enprofylline has been researched along with Bilateral Headache in 4 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed the efficacy and side effects of oral enprofylline in the maintenance therapy of 206 asthmatics 19 to 71 yr of age." | 9.06 | A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma. ( Bryant, D; Chapman, KR; Inouye, T; Koskinen, S; Marlin, GE; Mitchell, C; Osen, SS; Pedersen, B; Ringdal, N; Ruffin, R, 1989) |
| "Fifteen asthmatic outpatients were randomly treated during two periods of 14 days each with sustained-release preparations of either enprofylline (3-propyl-xanthine) or theophylline (Theo-Dur) in a double-blind crossover study." | 9.06 | Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison. ( Eriksson, G; Laursen, LC; Weeke, B, 1986) |
| "Twenty-five asthmatic outpatients were treated for 3 one-week periods with either enprofylline slowly eroding 300 mg tablets t." | 9.05 | Continuous treatment of asthmatic patients with enprofylline and theophylline. ( Johannesson, N; Laursen, LC; Weeke, B, 1984) |
| "We assessed the efficacy and side effects of oral enprofylline in the maintenance therapy of 206 asthmatics 19 to 71 yr of age." | 5.06 | A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma. ( Bryant, D; Chapman, KR; Inouye, T; Koskinen, S; Marlin, GE; Mitchell, C; Osen, SS; Pedersen, B; Ringdal, N; Ruffin, R, 1989) |
| "Fifteen asthmatic outpatients were randomly treated during two periods of 14 days each with sustained-release preparations of either enprofylline (3-propyl-xanthine) or theophylline (Theo-Dur) in a double-blind crossover study." | 5.06 | Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison. ( Eriksson, G; Laursen, LC; Weeke, B, 1986) |
| "Twenty-five asthmatic outpatients were treated for 3 one-week periods with either enprofylline slowly eroding 300 mg tablets t." | 5.05 | Continuous treatment of asthmatic patients with enprofylline and theophylline. ( Johannesson, N; Laursen, LC; Weeke, B, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laursen, LC | 2 |
| Johannesson, N | 1 |
| Weeke, B | 2 |
| Arnold, JD | 1 |
| Courtenay-Evans, RJ | 1 |
| Whitfield, R | 1 |
| O'Reilly, JF | 1 |
| Petrie, GR | 1 |
| Higgins, AJ | 1 |
| Swift, CG | 1 |
| Chapman, KR | 1 |
| Bryant, D | 1 |
| Marlin, GE | 1 |
| Mitchell, C | 1 |
| Ruffin, R | 1 |
| Inouye, T | 1 |
| Pedersen, B | 1 |
| Koskinen, S | 1 |
| Osen, SS | 1 |
| Ringdal, N | 1 |
| Eriksson, G | 1 |
4 trials available for enprofylline and Bilateral Headache
| Article | Year |
|---|---|
Continuous treatment of asthmatic patients with enprofylline and theophylline.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Double-Blind Method; Female; H | 1984 |
Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderly.
Topics: Aged; Bronchodilator Agents; Double-Blind Method; Female; Headache; Humans; Lung Diseases, Obstructi | 1990 |
A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma.
Topics: Adult; Aged; Asthma; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration | 1989 |
Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
Topics: Adult; Asthma; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Headache; | 1986 |